Stifel Nicolaus Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price

Teladoc Health (NYSE:TDOC) had its price target decreased by equities research analysts at Stifel Nicolaus from $9.00 to $8.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “hold” rating on the health services provider’s stock. Stifel Nicolaus’ target price suggests a potential upside of 13.15% from the stock’s current price.

A number of other equities analysts have also commented on TDOC. Royal Bank of Canada raised their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Jefferies Financial Group lowered their target price on Teladoc Health from $10.00 to $8.00 and set a “hold” rating for the company in a report on Monday, April 21st. The Goldman Sachs Group decreased their price objective on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a report on Monday, March 3rd. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Thursday. Finally, Evercore ISI lowered their price target on shares of Teladoc Health from $8.00 to $7.00 and set an “in-line” rating for the company in a research report on Thursday. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Teladoc Health presently has an average rating of “Hold” and an average price target of $9.81.

Teladoc Health Price Performance

Shares of TDOC stock opened at $7.07 on Thursday. The stock has a 50 day moving average price of $8.02 and a 200 day moving average price of $9.49. The firm has a market capitalization of $1.24 billion, a P/E ratio of -1.23 and a beta of 1.73. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a 52-week low of $6.35 and a 52-week high of $15.21.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, sell-side analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Buying and Selling

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.58% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

A number of institutional investors have recently bought and sold shares of the stock. Point72 Asset Management L.P. lifted its stake in shares of Teladoc Health by 33.6% during the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock worth $101,625,000 after buying an additional 2,813,568 shares during the period. Maple Rock Capital Partners Inc. grew its stake in Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock valued at $32,369,000 after purchasing an additional 2,331,000 shares during the last quarter. Two Sigma Investments LP acquired a new position in shares of Teladoc Health in the fourth quarter valued at about $18,348,000. Two Sigma Advisers LP lifted its holdings in shares of Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock worth $20,532,000 after purchasing an additional 1,537,094 shares during the period. Finally, Vanguard Group Inc. boosted its position in Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after buying an additional 1,029,829 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.